COJUTTI, PIER GIORGIO
COJUTTI, PIER GIORGIO
DIMEC - DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Docenti di ruolo di IIa fascia
A pre-post quasi-experimental study of antimicrobial stewardship exploring the impact of a multidisciplinary approach aimed at attaining an aggressive joint pharmacokinetic/pharmacodynamic target with ceftazidime/avibactam on treatment outcome of KPC-producing Klebsiella pneumoniae infections and on ceftazidime/avibactam resistance development
2025 Gatti, Milo; Rinaldi, Matteo; Cojutti, Pier Giorgio; Bonazzetti, Cecilia; Siniscalchi, Antonio; Tonetti, Tommaso; Ambretti, Simone; Tedeschi, Sara; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
Can a population pharmacokinetics model built on intermittent infusions accurately predict meropenem concentrations in children receiving continuous infusions?
2025 Cheng, Lucy; Kumar, Suchita; Cojutti, Pier Giorgio; Pea, Federico; Tang Girdwood, Sonya; Morales Junior, Ronaldo
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?
2025 Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Fornaro, Giacomo; Zagarrigo, Manuel; De Paolis, Massimiliano; Viale, Pierluigi; Pea, Federico
Epidemiological characteristics and management of Gram-negative bacteraemia in different immunocompromised hosts: Observational single-center study
2025 Toschi, A.; Pascale, R.; Gibertoni, D.; Pasquali, R.; Grechi, A.; Grassi, I.; Malosso, M.; Mangione, L.; Bonazzetti, C.; Tazza, B.; Rinaldi, M.; Amicucci, A.; Campoli, C.; Pasquini, Z.; Ambretti, S.; Cojutti, P. G.; Bonifazi, F.; Viale, P.; Giannella, M.
Feasibility of 24 h continuous-infusion cefiderocol administered by elastomeric pump in attaining an aggressive PK/PD target in the treatment of NDM-producing Klebsiella pneumoniae otomastoiditis
2025 Babich, Stella; Cojutti, Pier Giorgio; Gatti, Milo; Pea, Federico; Di Bella, Stefano; Monticelli, Jacopo
Is it Time to Move From Intermittent to Continuous Infusion Administration of Vancomycin?
2025 Cojutti, Pier Giorgio; Pea, Federico
Keeping the horse with the cart: are we underdosing tazobactam even when using continuous-infusion ceftolozane/tazobactam for effectively preventing resistance development by ESBL-producing Enterobacterales?
2025 Pai, Manjunath P.; Cojutti, Pier Giorgio; Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Leveraging Neural ODEs for Population Pharmacokinetics of Dalbavancin in Sparse Clinical Data
2025 Giacometti, Tommaso; Rocchi, Ettore; Cojutti, Pier Giorgio; Magnani, Federico; Remondini, Daniel; Pea, Federico; Castellani, Gastone
Population Pharmacokinetics of a Novel Oral Fosfomycin Prophylactic Scheme in the Plasma and Prostate of Patients Undergoing Endoscopic Surgery for Benign Prostatic Hyperplasia
2025 Cojutti, Pier Giorgio; Berrino, Pasquale Maria; Rotaru, Valeria; Bianchi, Lorenzo; Schiavina, Riccardo; Brunocilla, Eugenio; Viale, Pierluigi; Pea, Federico
Role of a TDM-guided strategy of isavuconazole for optimizing efficacy/safety outcomes in onco-hematological pediatric patients: a systematic review
2025 Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico
Targeting Pseudomonas aeruginosa resistance at the exposure frontier: a population PK/PD blueprint for ceftolozane/tazobactam continuous infusion
2025 Cojutti, Pier Giorgio; Pai, Manjunath P.; Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections
2025 Cojutti, Pier Giorgio; Gatti, Milo; Tedeschi, Sara; Zamparini, Eleonora; Meschiari, Marianna; Danzi, Maria; Menegotto, Giacomo; Cotrufo, Marco; Soavi, Laura; Chiari, Erika; Ripa, Marco; Mazzitelli, Maria; Crapis, Massimo; Cattelan, Annamaria; Parruti, Giustino; Russo, Alessandro; Zammarchi, Lorenzo; Tascini, Carlo; Viale, Pierluigi; Pea, Federico
Utility of a TDM-Guided Expert Clinical Pharmacological Advice Program for Optimizing the Use of Novel Beta-Lactam/Beta-Lactamase Inhibitor Combinations and Cefiderocol in a Tertiary University Hospital: An Interim Analysis
2025 Gatti, Milo; Cojutti, Pier Giorgio; Rinaldi, Matteo; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico
A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue
2024 Conti, Matteo; Giorgi, Beatrice; Barone, Rossella; Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico
An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients
2024 Cojutti, Pier Giorgio; Pai, Manjunath P; Gatti, Milo; Rinaldi, Matteo; Ambretti, Simone; Viale, Pierluigi; Pea, Federico
Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing Enterobacterales
2024 Cojutti, Pier Giorgio; Pai, Manjunath P.; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico
Effect of incremental tazobactam concentrations on the bactericidal activity of piperacillin against ESBL-producing enterobacterales clinical isolates causing bacteraemia
2024 Palombo, Marta; Gatti, Milo; Secci, Benedetta; Cojutti, Pier Giorgio; Pea, Federico; Gibellini, Davide; Gaibani, Paolo
Impact of attaining aggressive vs. conservative PK/PD target on the clinical efficacy of beta-lactams for the treatment of Gram-negative infections in the critically ill patients: a systematic review and meta-analysis
2024 Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico
Impact of Continuous Infusion Meropenem PK/PD Target Attainment on C-Reactive Protein Dynamics in Critically Ill Patients With Documented Gram-Negative Hospital-Acquired or Ventilator-Associated Pneumonia
2024 Troisi, Carla; Cojutti, Pier Giorgio; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; van Hasselt, Coen; Viale, Pierluigi; Pea, Federico
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for treating subacute and/or chronic staphylococcal infections
2024 Cojutti, Pier Giorgio; Gatti, Milo; Punt, Nieko; Douša, Jiři; Zamparini, Eleonora; Tedeschi, Sara; Viale, Pierluigi; Pea, Federico